文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

超重和肥胖个体使用草药后肠道微生物群的变化:系统评价。

Changes in the Gut Microbiota after the Use of Herbal Medicines in Overweight and Obese Individuals: A Systematic Review.

机构信息

Postgraduate Program in Food, Nutrition and Health (PPG-ANS), University of State of Rio de Janeiro, Rio de Janeiro 20550-170, Brazil.

Department of Applied Nutrition, University of State of Rio de Janeiro, Rio de Janeiro 20550-170, Brazil.

出版信息

Nutrients. 2023 May 5;15(9):2203. doi: 10.3390/nu15092203.


DOI:10.3390/nu15092203
PMID:37432344
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10181072/
Abstract

BACKGROUND: Herbal medicine is a low-cost treatment and has been increasingly applied in obesity treatment. Gut microbiota (GM) is strongly associated with obesity pathogenesis. METHODS: We conducted a systematic review guided by the question: "Does the use of herbal medicine change the GM composition in obese individuals?" Randomized clinical trials with obese individuals assessing the effects of herbal medicine intervention in GM were retrieved from the Medline, Embase, Scopus, Web of Science, and Cochrane Library databases, including the Cochrane Controlled Trials Register. Two reviewers independently extracted data using standardized piloted data extraction forms and assessed the study-level risk of bias using an Excel template of the Cochrane "Risk of bias" tool 2-RoB 2. RESULTS: We identified 1094 articles in the databases. After removing duplicates and reading the title and abstract, 14 publications were fully evaluated, of which seven publications from six studies were considered eligible. The herbs analyzed were , , , , W-LHIT and WCBE. The analysis showed that and had significant effects on weight loss herbal intervention therapy composed by five Chinese herbal medicines , , , , and (W-LHIT) and white common bean extract (WCBE) on GM, but no significant changes in anthropometry and laboratory biomarkers. CONCLUSIONS: Herbal medicine modulates GM and is associated with increased genera in obese individuals.

摘要

背景:草药是一种低成本的治疗方法,已越来越多地应用于肥胖症的治疗。肠道微生物群(GM)与肥胖症的发病机制密切相关。

方法:我们根据问题进行了系统评价:“使用草药是否会改变肥胖个体的 GM 组成?”从 Medline、Embase、Scopus、Web of Science 和 Cochrane Library 数据库中检索了评估草药干预对 GM 影响的肥胖个体的随机临床试验,包括 Cochrane 对照试验登记处。两名审查员使用标准化的试验数据提取表格独立提取数据,并使用 Cochrane“风险偏倚”工具 2-RoB 2 的 Excel 模板评估研究水平的风险偏倚。

结果:我们在数据库中确定了 1094 篇文章。在去除重复项并阅读标题和摘要后,对 14 篇出版物进行了全面评估,其中 6 项研究的 7 篇出版物被认为符合条件。分析的草药有、、、、、W-LHIT 和 WCBE。分析表明,五种中药组成的减肥草药干预疗法(、、、、和 W-LHIT)和白芸豆提取物(WCBE)对 GM 有显著影响,但对人体测量和实验室生物标志物没有显著变化。

结论:草药调节 GM,并与肥胖个体中丰度增加的属有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0115/10181072/19ff76173906/nutrients-15-02203-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0115/10181072/c8ed3b28906b/nutrients-15-02203-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0115/10181072/19ff76173906/nutrients-15-02203-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0115/10181072/c8ed3b28906b/nutrients-15-02203-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0115/10181072/19ff76173906/nutrients-15-02203-g002.jpg

相似文献

[1]
Changes in the Gut Microbiota after the Use of Herbal Medicines in Overweight and Obese Individuals: A Systematic Review.

Nutrients. 2023-5-5

[2]
Weight loss interventions for chronic asthma.

Cochrane Database Syst Rev. 2012-7-11

[3]
Ganoderma lucidum (Reishi mushroom) for cancer treatment.

Cochrane Database Syst Rev. 2016-4-5

[4]
Green tea for weight loss and weight maintenance in overweight or obese adults.

Cochrane Database Syst Rev. 2012-12-12

[5]
Ganoderma lucidum (Reishi mushroom) for cancer treatment.

Cochrane Database Syst Rev. 2012-6-13

[6]
Herbal and dietary therapies for primary and secondary dysmenorrhoea.

Cochrane Database Syst Rev. 2001

[7]
Herbal medicines for viral myocarditis.

Cochrane Database Syst Rev. 2012-11-14

[8]
Herbal medicine for low back pain: a Cochrane review.

Spine (Phila Pa 1976). 2007-1-1

[9]
Diet, physical activity and behavioural interventions for the treatment of overweight or obese children from the age of 6 to 11 years.

Cochrane Database Syst Rev. 2017-6-22

[10]
Strategies for enhancing the implementation of school-based policies or practices targeting risk factors for chronic disease.

Cochrane Database Syst Rev. 2017-11-29

引用本文的文献

[1]
Gut microbiota from Mori fructus (Morus alba L.) polyphenols and polysaccharides-dosed mice activates the PPARα/PGC-1α signaling pathway to mitigate HFD-induced metabolic syndrome in mice.

Sci Rep. 2025-8-1

[2]
Dilemmas in Elderly Diabetes and Clinical Practice Involving Traditional Chinese Medicine.

Pharmaceuticals (Basel). 2024-7-16

[3]
Exploring the underlying mechanisms of obesity and diabetes and the potential of Traditional Chinese Medicine: an overview of the literature.

Front Endocrinol (Lausanne). 2023

本文引用的文献

[1]
Clinical efficacy of weight loss herbal intervention therapy and lifestyle modifications on obesity and its association with distinct gut microbiome: A randomized double-blind phase 2 study.

Front Endocrinol (Lausanne). 2023

[2]
White common bean extract remodels the gut microbiota and ameliorates type 2 diabetes and its complications: A randomized double-blinded placebo-controlled trial.

Front Endocrinol (Lausanne). 2022

[3]
Obesity and gut-microbiota-brain axis: A narrative review.

J Clin Lab Anal. 2022-5

[4]
Human Stool Preservation Impacts Taxonomic Profiles in 16S Metagenomics Studies.

Front Cell Infect Microbiol. 2022

[5]
Dysbiotic Gut Bacteria in Obesity: An Overview of the Metabolic Mechanisms and Therapeutic Perspectives of Next-Generation Probiotics.

Microorganisms. 2022-2-16

[6]
Leaf Supplementation as a Glycemic Control Strategy in Subjects with Prediabetes.

Nutrients. 2021-12-24

[7]
Gut Microbiome Composition in Obese and Non-Obese Persons: A Systematic Review and Meta-Analysis.

Nutrients. 2021-12-21

[8]
Building up a clinical microbiota profiling: a quality framework proposal.

Crit Rev Microbiol. 2022-5

[9]
The Relationship between the Gut Microbiome and Metformin as a Key for Treating Type 2 Diabetes Mellitus.

Int J Mol Sci. 2021-3-30

[10]
Recognizing the Benefits of Pre-/Probiotics in Metabolic Syndrome and Type 2 Diabetes Mellitus Considering the Influence of as a Key Gut Bacterium.

Microorganisms. 2021-3-17

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索